4243
document
September 7, 2016 — 00:00
At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
document
September 7, 2016 — 00:00
German version - At its annual Investor Day in Paris today, SCOR presents its new three-year strategic plan, “Vision in Action” covering the period mid-2016 to mid-2019.
document
September 7, 2016 — 00:00
On the proposal of its committee members in charge of nominations, SCOR’s Board of Directors has unanimously decided to propose, at the Combined Shareholders’ Meeting of 27 April 2017, the renewal of Denis Kessler’s d
Expert views
August 30, 2016
Alexander Fleming’s discovery of Penicillin in 1928 marked one of the proudest achievements of 20th Century medicine. A decade of R&D later and suddenly mankind had the ability to fight a whole class of diseases.
Press Releases
The redemption of the two debts was already prefinanced.
Press Releases
SCOR completed the calls of the entire balance of its EUR 350 million and CHF 650 million undated subordinated note lines on 28 July and 2 August 2016 respectively.
document
August 3, 2016 — 00:00
SCOR issued the EUR 350 million deeply subordinated notes on 28 July 2006. The amount outstanding was EUR 257 million.
